Open AccessComparative role of tenofovir versus entecavir for treating patients with hepatitis B virus-related acute on chronic liver failure
Author(s) -
Sharker Mohammad Shahadat Hossain,
Mamun Al Mahtab,
Debasish Das,
Sheikh Mohammad Noor-E-Alam,
Ayub Al Mamun,
Md. Sakirul Islam Khan,
Sk. Md. Fazle Akbar,
Zakiur Rahman,
Salimur Rahman
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_2299_20
Subject(s) - entecavir , medicine , gastroenterology , hepatitis b virus , tenofovir , hepatitis b , immunology , virus , lamivudine , human immunodeficiency virus (hiv)
The aim of the study was to compare the safety and efficacy of tenofovir versus entecavir for treatment of naive acute on chronic liver failure (ACLF) due to hepatitis B virus (HBV) (ACLF-B).